|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota显示文摘Decreased muscle mass and function,also known as sarcopenia,is common in patients with cirrhosis and is associated with a poor prognosis.Although the pathogenesis of this disorder has not been fully elucidated,a disordered gutmuscle axis probably plays an important role.Decreased barrier function of the gut and liver,gut dysbiosis,and small intestinal bacterial overgrowth(SIBO)can lead to increased blood levels of ammonia,lipopolysaccharides,pro-inflammatory mediators,and myostatin.These factors have complex negative effects on muscle mass and function.Drug interventions that target the gut microbiota(long-term use of rifaximin,lactulose,lactitol,or probiotics)positively affect most links of the compromised gut-muscle axis in patients with cirrhosis by decreasing the levels of hyperammonemia,bacterial translocation,and systemic inflammation and correcting gut dysbiosis and SIBO.However,although these drugs are promising,they have not yet been investigated in randomized controlled trials specifically for the treatment and prevention of sarcopenia in patients with cirrhosis.No data exist on the effects of fecal transplantation on most links of gut-muscle axis in cirrhosis;however,the results of animal experimental studies are promising. | Roman Maslennikov Aliya Alieva Elena Poluektova Yury Zharikov Andrey Suslov Yana Letyagina Ekaterina Vasileva Anna Levshina Evgenii Kozlov Vladimir Ivashkin | 2023 | World Journal of Gastroenterology2023，29，27： | 2 |
| 2 | Application of ion-exchange chromatography for the production of human albumin 显示文摘 | Vasileva R Jakabmol L Hasko F | 1981 | J Chromatogr1981，216，： | 1 |
| 3 | Rubber-modified polystyrene compositions显示文摘 | Trifonova D Vasileva S | 1992 | Journal of Materials Science1992，27，13： | 1 |
| 4 | Comparative profile for COVID-19 cases from China and North America: Clinical symptoms, comorbidities and disease biomarkers显示文摘BACKGROUND Large inter-individual and inter-population differences in the susceptibility to and outcome of severe acute respiratory syndrome coronavirus 2 or coronavirus disease 2019(COVID-19)have been noted.Understanding these differences and how they influence vulnerability to infection and disease severity is critical to public health intervention.AIM To analyze and compare the profile of COVID-19 cases between China and North America as two regions that differ in many environmental,host and healthcare factors related to disease risk.METHODS We conducted a meta-analysis to examine and compare demographic information,clinical symptoms,comorbidities,disease severity and levels of disease biomarkers of COVID-19 cases from clinical studies and data from China(105 studies)and North America(19 studies).RESULTS COVID-19 patients from North America were older than their Chinese counterparts and with higher male:Female ratio.Fever,cough,fatigue and dyspnea were the most common clinical symptoms in both study regions(present in about 30%to 75%of the cases in both regions).Meta-analysis for the prevalence of comorbidities(such as obesity,hypertension,diabetes,cardiovascular diseases,chronic obstructive pulmonary disease,cancer,and chronic kidney diseases)in COVID-19 patients were all significantly more prevalent in North America compared to China.Comorbidities were positively correlated with age but at a significantly younger age range in China compared to North American.The most prevalent infection outcome was acute respiratory distress syndrome which was 2-fold more frequent in North America than in China.Levels of C-reactive protein were 4.5-fold higher in the North American cases than in cases from China.CONCLUSION The differences in the profile of COVID-19 cases from China and North America may relate to differences in environmental-,host-and healthcare-related factors between the two regions.Such inter-population differences-together with intrapopulation variability-underline the need to characterize the effect of health inequities and inequalities on public health response to COVID-19 and can assist in preparing for the re-emergence of the epidemic. | Alaa Badawi Denitsa Vasileva | 2021 | World Journal of Clinical Cases2021，9，1： | 1 |
| 5 | immobilization of glucose oxidase using acrylonitrile copolymer membranes显示文摘 | Godjevargova T Dimov A Vasileva N | 1994 | J Membr Sci1994，88，： | 1 |
| 6 | Inflammatory cytokines at admission—Independent prognostic markers in patients with acute coronary syndrome and hyperglycaemia显示文摘 | Zheyna Vlaeva Cherneva Stefan Veselinov Denchev Mariana Vasileva Gospodinova Adelina Cakova Radostina Vlaeva Cherneva | 2012 | Acute Cardiac Care2012，，1： | 1 |
| 7 | Management of paddlefish fry and juveniles in Bulgarian conditions 显示文摘 | Tania Hubenova Angel Zaikov Penka Vasileva | 2007 | Aquacult Int2007，15，： | 1 |
| 8 | Direct synthesis of thermally responsive DMA/NIPAM diblock and DMA/NIPAM/DMA triblock copolymers via aqueous, room temperature RAFT polymerization 显示文摘 | Convertine A J Lokitz B S Vasileva Y | 2006 | Macromolecules2006，39，5： | 1 |
| 9 | Dynamic mechanical and thermal properties of modified poly (propylene) wood fiber compo- sites 显示文摘 | Hristov V Vasileva S | 2003 | Macromol Mater Eng2003，288，： | 1 |
| 10 | Purification and characterization of glucosyltransferases from new strains Leuconostoc mesenteroides显示文摘 | VASILEVA T IVANOVA I ILIEV I | 2009 | Biotechnology&Biotechnological Equipment2009，23，1： | 1 |
| 11 | Deformation mechanisms and mechanical properties of modified polypmpylene/wood fiber composites 显示文摘 | Hristov V N Vasileva S T | 2004 | Polym Compos2004，25，5： | 1 |
| 12 | Modem methods for diagnosis of Gardnerella infection显示文摘 | Makarova LN Kravtsov EG Vasileva EA | 2000 | Bull Exp Biol Med2000，130，8： | 1 |
| 13 | Deforma- tion Mechanisms and Mechanical Properties of Modified Polypropylene/Wood Fiber Composites 显示文摘 | HFIATOV V N VASILEVA S T LACH M | 2004 | Polymer Com- posite2004，25，5： | 1 |
| 14 | Cell-to cell cross-talk between mesenchymal stem cells and cardio myocytes in co-culture显示文摘 | Plotnikov EY Khryapenkova TG Vasileva AK | 2008 | J Cell Mol Med2008，，： | 1 |
| 15 | On the surface structure of coatings formed by anodic spark method 显示文摘 | Rudnev V S Vasileva M S Lukiyanchul I V | 2004 | Protection of Metal2004，40，4： | 1 |
| 16 | On the surface structure of coatings formed by anodic spark method 显示文摘 | Rudnev V S Vasileva M S Lukiyanehuk I V | 2004 | Protection of Metal2004，40，4： | 1 |
| 17 | Study of the effect of some organic solvents on the activity and stability of glucose oxidase 显示文摘 | Vasileva N Godjevargova T | 2005 | Materials Science and Engineering C2005，25，： | 1 |
| 18 | Mirabiquinone, a new unsymmetrical binaphthoqui- none from the sea urchin Scaphechinus mirabilis 显示文摘 | Mishchenko N P Vasileva E A Fedoreyev S A | 2014 | Tetrahedron Letters2014，55，： | 1 |
| 19 | Inhibition of GSK-3β decreases the ischemiainduced death of renal cells显示文摘 | Vasileva AK Plotnikov EY Kazachenko AV | | 0，，03： | 1 |
| 20 | Pancrelipase delayedrelease capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized triM显示文摘 | Whitcomb DC Lehman GA Vasileva G | 2010 | Am J Gastroenterol2010，105，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员